نتائج البحث - Matthew D. Troyer

  • يعرض 1 - 13 نتائج من 13
تنقيح النتائج
  1. 1
    Lipid Rafts Mediate the Synaptic Localization of α-Synuclein

    Lipid Rafts Mediate the Synaptic Localization of α-Synuclein حسب Doris L. Fortin, Matthew D. Troyer, Ken Nakamura, Shinichiro Kubo, Malcolm D. Anthony, Robert H. Edwards

    منشور في 2004
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  2. 2
    Effects of Suvorexant, an Orexin Receptor Antagonist, on Respiration during Sleep In Patients with Obstructive Sleep Apnea

    Effects of Suvorexant, an Orexin Receptor Antagonist, on Respiration during Sleep In Patients with Obstructive Sleep Apnea حسب Hong Sun, John Palcza, Deborah Card, Adrianna Gipson, Russell Rosenberg, Meir H. Kryger, Christopher Lines, John A. Wagner, Matthew D. Troyer

    منشور في 2016
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  3. 3
    Effects of suvorexant, an orexin receptor antagonist, on breathing during sleep in patients with chronic obstructive pulmonary disease

    Effects of suvorexant, an orexin receptor antagonist, on breathing during sleep in patients with chronic obstructive pulmonary disease حسب Hong Sun, John Palcza, Russell Rosenberg, Meir H. Kryger, Tara Siringhaus, Janice Rowe, Christopher Lines, John A. Wagner, Matthew D. Troyer

    منشور في 2015
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  4. 4
    The Expression of Vesicular Glutamate Transporters Defines Two Classes of Excitatory Synapse

    The Expression of Vesicular Glutamate Transporters Defines Two Classes of Excitatory Synapse حسب Robert T. Fremeau, Matthew D. Troyer, Ingrid Pahner, Gro Owren Nygaard, Cindy Tran, Richard J. Reimer, Elizabeth E. Bellocchio, Doris L. Fortin, Jon Storm‐Mathisen, Robert H. Edwards

    منشور في 2001
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  5. 5
    α-Synuclein Overexpression in PC12 and Chromaffin Cells Impairs Catecholamine Release by Interfering with a Late Step in Exocytosis

    α-Synuclein Overexpression in PC12 and Chromaffin Cells Impairs Catecholamine Release by Interfering with a Late Step in Exocytosis حسب Kristin E. Larsen, Yvonne Schmitz, Matthew D. Troyer, Eugene V. Mosharov, Paula Dietrich, Abrar Z. Quazi, Magali Savalle, Venu M. Nemani, Farrukh A. Chaudhry, Robert H. Edwards, Leonidas Stefanis, David Sulzer

    منشور في 2006
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  6. 6
    α-Synuclein Overexpression Increases Cytosolic Catecholamine Concentration

    α-Synuclein Overexpression Increases Cytosolic Catecholamine Concentration حسب Eugene V. Mosharov, Roland G. W. Staal, Jordi Bové, Delphine Prou, Anthonia Hananiya, Dmitriy Markov, Nathan W. Poulsen, Kristin E. Larsen, Candace Moore, Matthew D. Troyer, Robert H. Edwards, Serge Przedborski, David Sulzer

    منشور في 2006
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  7. 7
    On-the-road driving performance the morning after bedtime use of suvorexant 15 and 30 mg in healthy elderly

    On-the-road driving performance the morning after bedtime use of suvorexant 15 and 30 mg in healthy elderly حسب Annemiek Vermeeren, Eva Vets, Eric Vuurman, Anita C.M. Van Oers, Stefan Jongen, Tine Laethem, Ingeborg Heirman, An Bautmans, John Palcza, Xiadong Li, Matthew D. Troyer, Rebecca E. Wrishko, Jacqueline B. McCrea, Hong Sun

    منشور في 2016
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  8. 8
    On-the-Road Driving Performance the Morning after Bedtime Use of Suvorexant 20 and 40 mg: A Study in Non-Elderly Healthy Volunteers

    On-the-Road Driving Performance the Morning after Bedtime Use of Suvorexant 20 and 40 mg: A Study in Non-Elderly Healthy Volunteers حسب Annemiek Vermeeren, Hong Sun, Eric Vuurman, Stefan Jongen, C. J. Van Leeuwen, Anita C.M. Van Oers, John Palcza, Xiadong Li, Tine Laethem, Ingeborg Heirman, An Bautmans, Matthew D. Troyer, Rebecca E. Wrishko, Jacqueline B. McCrea

    منشور في 2015
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  9. 9
    Cognitive performance and neuropsychiatric symptoms in early, untreated Parkinson's disease

    Cognitive performance and neuropsychiatric symptoms in early, untreated Parkinson's disease حسب Daniel Weintraub, Tanya Simuni, Chelsea Caspell‐Garcia, Christopher S. Coffey, Shirley Lasch, Andrew Siderowf, Dag Aarsland, Paolo Barone, David J. Burn, Lana M. Chahine, Jamie L. Eberling, Alberto J. Espay, Eric D. Foster, James B. Leverenz, Irene Litvan, Irene Hegeman Richard, Matthew D. Troyer, Keith A. Hawkins

    منشور في 2015
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  10. 10
    <scp>LRRK2</scp> Inhibition by <scp>BIIB122</scp> in Healthy Participants and Patients with Parkinson's Disease

    <scp>LRRK2</scp> Inhibition by <scp>BIIB122</scp> in Healthy Participants and Patients with Parkinson's Disease حسب Danna Jennings, Sarah Huntwork‐Rodriguez, Maurits F. J. M. Vissers, Vinay M. Daryani, Dolores Diaz, Marisa S. Goo, John J. Chen, Romeo Maciuca, Kyle Fraser, Omar S. Mabrouk, Jeroen van de Wetering de Rooij, Jules A. A. C. Heuberger, Geert Jan Groeneveld, Marie T. Borin, Andrés Cruz‐Herranz, Danielle Graham, Kimberly Scearce‐Levie, Javier De Vicente, Anastasia G. Henry, Peter Chin, Carole Ho, Matthew D. Troyer

    منشور في 2023
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  11. 11
    Safety, pharmacokinetics and target engagement of novel <scp>RIPK1</scp> inhibitor <scp>SAR443060</scp> (<scp>DNL747</scp>) for neurodegenerative disorders: Randomized, <scp>placebo‐controlled</scp>, <scp>double‐blind</scp> phase I/Ib studies in healthy subjects and patients

    Safety, pharmacokinetics and target engagement of novel <scp>RIPK1</scp> inhibitor <scp>SAR443060</scp> (<scp>DNL747</scp>) for neurodegenerative disorders: Randomized, <scp>placeb... حسب Maurits F. J. M. Vissers, Jules A. A. C. Heuberger, Geert Jan Groeneveld, Jerome Oude Nijhuis, Peter Paul De Deyn, Salah Hadi, Jeffrey M. Harris, Richard M. Tsai, Andrés Cruz‐Herranz, Fen Huang, Vincent Tong, Rebecca Erickson, Yuda Zhu, Kimberly Scearce‐Levie, Jennifer Hsiao‐Nakamoto, Xinyan Tang, Megan Chang, Brian M. Fox, Anthony A. Estrada, Robert J. Pomponio, Miguel Alonso‐Alonso, Moshe Zilberstein, Nazem Atassi, Matthew D. Troyer, Carole Ho

    منشور في 2022
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  12. 12
    Molecular architecture determines brain delivery of a transferrin receptor–targeted lysosomal enzyme

    Molecular architecture determines brain delivery of a transferrin receptor–targeted lysosomal enzyme حسب Annie Arguello, Cathal Mahon, Meredith Calvert, Darren Chan, Jason C. Dugas, Michelle E. Pizzo, Elliot R. Thomsen, Roni Chau, Lorna A. Damo, Joseph Duque, Meng Fang, Tina Giese, Do Jin Kim, Nicholas Liang, Hoang N. Nguyen, Hilda Solanoy, Buyankhishig Tsogtbaatar, Julie C. Ullman, Junhua Wang, Mark S. Dennis, Dolores Diaz, Kannan Gunasekaran, Kirk R. Henne, Joseph W. Lewcock, Pascal E. Sanchez, Matthew D. Troyer, Jeffrey M. Harris, Kimberly Scearce‐Levie, Lu Shan, Ryan J. Watts, Robert G. Thorne, Anastasia G. Henry, Mihalis S. Kariolis

    منشور في 2022
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  13. 13
    A framework for translating tauopathy therapeutics: Drug discovery to clinical trials

    A framework for translating tauopathy therapeutics: Drug discovery to clinical trials حسب Howard Feldman, Jeffrey L. Cummings, Adam L. Boxer, Adam M. Staffaroni, David S. Knopman, Stacey J. Sukoff Rizzo, Paul R. Territo, Steven E. Arnold, Clive Ballard, Dirk Beher, Bradley F. Boeve, Penny A. Dacks, Kristophe Diaz, Colin Ewen, Brian Fiske, María Isabel González, Glenn A. Harris, Beth J. Hoffman, Terina N. Martinez, Eric McDade, Laura K. Nisenbaum, Jose‐Alberto Palma, Melanie Quintana, Gil D. Rabinovici, Jonathan D. Rohrer, Howard J. Rosen, Matthew D. Troyer, Doo Yeon Kim, Rudolph E. Tanzi, Henrik Zetterberg, Nick Ziogas, Patrick C. May, Amy Rommel

    منشور في 2024
    احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:

أدوات البحث: